Proposed Registration Decision PRD2025-01, Flg22-Bt Peptide, Vismax Seed Treatment, and Vismax Row Crop

Health Canada’s Pest Management Regulatory Agency (PMRA), pursuant to subsection 28(1) of the Pest Control Products Act, is proposing registration for the sale and use of Flg22-Bt Peptide Technical, Vismax Seed Treatment, and Vismax Row Crop, containing the active ingredient Flg22-Bt peptide, to control fungal plant disease caused by Fusarium species in soybean and wheat.

How to get involved

This consultation is open for comment from 12 February 2025 to 29 March 2025 (45 calendar days). Open the “Consultation Summary” to access the document.

If you would like to comment, see the Pest Management Regulatory Agency Publications Section page for contact information. Please be sure to include the title of the consultation document on which you are commenting.

Health Canada will consider all comments received up to 45 days from the date of publication of this document (by 29 March 2025) before making a final decision on the proposed registration for Flg22-Bt Peptide, Vismax Seed Treatment, and Vismax Row Crop

Reporting to Canadians

Health Canada will make the results of this consultation available on this website. Once the decision on Flg22-Bt Peptide, Vismax Seed Treatment, and Vismax Row Crop is finalized, the PMRA will post a Registration Decision on the Pesticides and Pest Management Reports and Publications portion of Canada.ca.

If you have any questions, contact the Pest Management Information Service.

Interested in our other consultations? Sign up and stay informed about topics that matter to you.